SUTRO
LIVE

Serial Number

97855620

Owner

Sutro Biopharma, Inc.

Attorney

Karen Won

First Use Date

Jul 5, 2017

Filing Date

Mar 24, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SUTRO Trademark

Serial Number: 97855620

SUTRO is a trademark filed by Sutro Biopharma, Inc. on March 24, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Sutro Biopharma, Inc.

111 Oyster Point Blvd.
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

March 24, 2023

Registration Date

Not Registered

First Use Anywhere

July 5, 2017

First Use in Commerce

July 5, 2017

Published for Opposition

May 21, 2024

Goods & Services

Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations

Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use

Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 29, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 29, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 3, 2026 CNRT
SOU TEAS EXTENSION RECEIVED
Jan 13, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2026 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 2, 2026 SUPC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 2, 2025 EX2G
USE AMENDMENT FILED
Jul 1, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 1, 2025 EISU
SOU EXTENSION 2 FILED
Jul 1, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 16, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 15, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 15, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 17, 2024 XAEC
ASSIGNED TO LIE
Apr 17, 2024 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 16, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 16, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 16, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 18, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2023 NWOS
NEW APPLICATION ENTERED
Mar 28, 2023 NWAP